| Biomarker ID | 1692 |
| PMID | 25967040 |
| Year | 2015 |
| Biomarker | sE-Cadherin |
| Biomarker Basis | Concentration Based |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathway include: Cell junction organization; CDK-mediated phosphorylation and removal of Cdc6; ERK Signaling; Apoptotic cleavage of cellular proteins; Listeria monocytogenes entry into host cells |
| Experiment | Gleason Pattern 3 Vs 4 Vs 5 |
| Type of Biomarker | Prognostic |
| Cohort | 165 PCa patients and 19 controls were chosen for analysis. 38 patients with Gleason pattern 3, 104 with 4, 33 with 5 |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.02 |
| Method Used | ELISA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |